LRG1 and malignant colon neoplasm: Proteomic analysis of the serum-derived EVs unveiled secreted protein acidic and cysteine rich (SPARC) and leucine rich alpha-2-glycoprotein 1 (LRG1) can serve as diagnostic markers for colon cancer and predict tumor recurrence.